Drawing for ZOGUZE

USPTO serial 97718932

ZOGUZE

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
Examiner
HWANG, JOHN C B
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with ZOGUZE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany Trunko

Tiffany Trunko Eli Lilly and CompanyLilly Corporate CenterIndianapolis, IN 46285United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 15, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2026EX5GSOU EXTENSION 5 GRANTED
Aug 14, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
May 28, 2026EXT5SOU EXTENSION 5 FILED
May 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 18, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 17, 2025EX4GSOU EXTENSION 4 GRANTED
Nov 17, 2025EXT4SOU EXTENSION 4 FILED
Nov 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2025EX3GSOU EXTENSION 3 GRANTED
May 14, 2025EXT3SOU EXTENSION 3 FILED
May 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 19, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2024EX2GSOU EXTENSION 2 GRANTED
Nov 19, 2024EXT2SOU EXTENSION 2 FILED
Nov 19, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2024EX1GSOU EXTENSION 1 GRANTED
May 16, 2024EXT1SOU EXTENSION 1 FILED
May 16, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2023DOCKASSIGNED TO EXAMINER
Jan 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance